$50B Opioid Trial Starts With Warring Views Of Drug Marketing
California counties and major drugmakers locked horns Monday at the start of the second trial in a historic surge of opioid-crisis litigation, lashing one another with dramatically divergent depictions of how...To view the full article, register now.
Already a subscriber? Click here to view full article